COVID-19 effect on TB presentation and outcome

Int J Tuberc Lung Dis. 2022 Apr 1;26(4):375-377. doi: 10.5588/ijtld.22.0036.
No abstract available

MeSH terms

  • Antitubercular Agents / therapeutic use
  • COVID-19*
  • Humans
  • Tuberculosis, Pulmonary* / drug therapy

Substances

  • Antitubercular Agents